It's Wednesday, September 17. Today, we’ll explore groundbreaking developments in cancer treatment, the fight against dengue fever, and new strides in women’s health with a recently approved medical device.
Kilder
- Nature: Tumour-specific STING agonist synthesis via a two-component prodrug system - Nature
- Nature: Macrovascular and microvascular outcomes of metabolic surgery versus GLP-1 receptor agonists in patients with diabetes and obesity - Nature
- Nature: How billions of hacked mosquitoes and a vaccine could beat the deadly dengue virus - Nature
- Statnews: New startup wants to make novel bispecific antibodies for immune diseases - statnews.com
- Fiercebiotech: Pharma execs cite ‘challenging’ environment during grilling by UK lawmakers over R&D pullback - Fierce Biotech
- Biospace: US FDA Approves First Medical Device For Women With Asherman Syndrome - BioSpace
Oppsummeringen og talen er laget med KI. Kildelenkene viser opphavet og er ikke en anbefaling av TellMe fra mediene.